Clinical solutions

Aiforia® Colorectal Cancer QuantCRC

The prognostic AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for treatment decisions. The AI model was developed and validated in collaboration with the Mayo Clinic. 


 Learn more            Contact us  

QuantCRC_image 1-1


QuantCRC_monitor 1

Development and validation

Prognostic AI model identifies different tissue characteristics in colorectal cancer patient samples, and combined with two other clinical parameters, it produces a colorectal cancer recurrence risk score.

  • Dr. Rish Pai from Mayo Clinic trained a highly advanced AI model for detecting multiple pathologic features of colorectal carcinoma. He used Aiforia® Create end to end by annotating all the training data himself.
  • QuantCRC was verified and validated in Aiforia® Platform using whole slide images and against reviews by independent pathologists from eight different hospitals.
  • The effectiveness of the AI model has been demonstrated through retrospective analysis in multiple independent patient sample cohorts¹ ² ³. 

1. Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival. Pai, R K. et al. Gastroenterology, Volume 163, Issue 6, 1531–1546.e8 (2022)

2. Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters. Pai R K et al. Histopathology 79, Issue 3, 391–405 (2021)

3. Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC. Wu et al. Clinical Cancer Research, Epub ahead of print. doi: 10.1158/1078-0432.CCR-23-3211 (2024)

Using Prognostic AI Models in Pathology:
Case Colorectal Cancer

Join our upcoming webinar on June 13, 2024 

Potential value in clinical use in the future 

About us_Investors
Improved risk stratification

QuantCRC improves accuracy in predicting recurrence-free survival for colorectal cancer patients by identifying patients who might benefit from more intense treatment or closer monitoring.

ic_decisions with confidence_pink
Tailored treatment plans

Patients can receive tailored treatment based on their individual prognosis.

ic_reduce costs_pink
Cost savings in treatment

Implementing the prognostic QuantCRC AI model can lead to substantial cost savings in treatment by optimizing the targeting of expensive chemotherapy drugs.


Contact us

Are you interested in hearing more about QuantCRC or Aiforia's other AI models?

We are happy to organize a virtual demo for you or answer any questions you may have. Fill out the form, and we will contact you shortly.